Planning in consultancy is particularly complicated, especially for a company like GENESIS Biomed, which has a very varied project portfolio, with a large number of projects and with clients with very...
Read more
La Universidad Católica de Murcia y la empresa Azierta, consultora especializada en ciencias de la vida y salud, han firmado un convenio de colaboración para la puesta en marcha de la Cátedra ‘Li...
Read more
Safety reporting is a crucial aspect of a successful clinical investigation for medical devices. In addition to the Good Clinical Practice (GCP), stakeholders are required to comply with the Medical D...
Read more
We organized three great Webinars about veterinary regulation, ISO IDMP and DADI; AsphaWellbeing has been reshaped!; we launched a Regulatory Submissions ATLAS with the main regional eSubmissions requ...
Read more
Azbil Telstar has announced the appointment of Emili Pablos and Jordi Puig as Managing Directors of the company. Together with Jochen Dick, who will keep leading the company as Chief Executive Officer...
Read more
La UAM, a través de su unidad de emprendimiento (UAM Emprende) junto al proyecto DIH·Bio, con la colaboración de GENESIS Biomed y la financiación de la Comunidad de Madrid, ha iniciado el proceso ...
Read more
Jordi Ortiz: “We have designed the implementation of annual quality plans that will allow us to reach the standards required by ISO9001”. Jordi Ortiz holds a degree in Chemistry (specialising in ...
Read more
The main objective of any innovation generated by a health research centre or public hospital is to reach the market as soon as possible, i.e., to ensure that potential users, be they doctors, patient...
Read more
Within the framework of the Venture Builder Programme, a mechanism promoted by Xartec Salut to accelerate the creation of spin-off companies, GENESIS Biomed has collaborated during the years 2021 and ...
Read more
The new Law on Science, Technology and Innovation (Law 17/2022) does not remove the obligation for public institutions to participate in a spin-off if they want to lift the incompatibilities of resear...
Read more
GENESIS Biomed, a consultancy firm that specialises in early-stage R&D projects in the biomedical sector, expects to close out 2022 with record turnover of €1.6 million, up 28% from the previous yea...
Read more
Cellab expects to complete the path initiated in 2019 to launch a new line of activity this 2023, focused on the cell therapies manufacture and R&D development for third parties, with tailor-made serv...
Read more
AtCDF3 gene induced greater production of sugars a...
Un estudio con datos de los últimos 35 años, ind...
Un equipo de investigadores de la Universidad Juli...
En nuestro post hablamos sobre este interesante tipo de célula del...
Palobiofarma S.L. is pleased to announce the “last patient last visi...
